Photo taken from Fadi Haddad/Twitter
Mar 2, 2024, 18:48
Fadi Haddad: Out in NEJM rusfertide in Polycythemia vera
Fadi Haddad, Assistant Professor, Leukemia Department MD Anderson Cancer Center, Houston, shared a post on X/Twitter:
“Out in NEJM rusfertide in Polycythemia vera
Rusfertide = hepcidin mimetic
S/C weekly
N=59 in Phase 2 (Rusfertide=30, Placebo=29)
Ht control and absence of phlebotomy, 60% vs 17%
Improved symptoms with rusfertide”
Source: Fadi Haddad/X